Literature DB >> 36064710

Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.

Kentaro Nishi1, Masao Ogura1, Naotaka Tamai2, Masafumi Gima3, Kentaro Ide3, Goro Koinuma2, Koichi Kamei1, Shuichi Ito4,5.   

Abstract

Entities:  

Year:  2022        PMID： 36064710      PMCID： PMC9446570          DOI： 10.1186/s12969-022-00736-0

Source DB:  PubMed          Journal:  Pediatr Rheumatol Online J        ISSN： 1546-0096            Impact factor:   3.413


× No keyword cloud information.
  1 in total

Review 1.  Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.

Authors:  Kentaro Nishi; Masao Ogura; Naotaka Tamai; Masafumi Gima; Kentaro Ide; Goro Koinuma; Koichi Kamei; Shuichi Ito
Journal:  Pediatr Rheumatol Online J       Date:  2022-08-04       Impact factor: 3.413
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.